Clinical outcomes and complications of S53P4 bioactive glass in chronic osteomyelitis and septic non-unions: a retrospective single-center study.

Simone Daniel GattiDiego GaddiMarco TuratiGiulio LeoneJacobus J ArtsFabio PessinaMattia CarminatiGiovanni ZattiLaura De RosaMarco Bigoni

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)

S53P4 bioactive glass is an effective and safe therapeutic option in the treatment of chronic osteomyelitis and septic non-unions because of its unique antibacterial properties, but also for its ability to generate a growth response in the remaining healthy bone at the bone-glass interface.

Keyphrases

bone mineral density
acute kidney injury
soft tissue
bone loss
bone regeneration
risk factors
postmenopausal women
anti inflammatory
silver nanoparticles